VitaLeech Bioscience N.V. develops a recombinant enzyme for the treatment of periodontitis, a form of inflammation of the gum that may result in the loss of teeth.
Periodonditis is a widespread disorder among 40+ year-olds. Oral care products with a proven efficacy against periodontitis do not exist yet.
Current product development stage: start of clinical proof-of concept study.
